FAQ/Help |
Calendar |
Search |
Today's Posts |
01-17-2012, 04:30 PM | #1 | ||
|
|||
News Gatherer
Community Support Team
|
HealthDay - TUESDAY, Jan. 17 (HealthDay News) -- Combining two drugs that target an aggressive type of breast cancer known as HER2-positive appears to work better than using either drug alone, researchers report.
Read the full article... (From Yahoo Diseases) |
||
Reply With Quote |
"Thanks for this!" says: | eva5667faliure (01-20-2012) |
Reply |
Thread Tools | |
Display Modes | |
|
|